Source:http://linkedlifedata.com/resource/pubmed/id/11534265
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-9-5
|
pubmed:abstractText |
Antiphospholipid antibody positive patients are at risk for venous and arterial thrombosis. The risk of recurrent thromboembolism is high. Although the standard of care is high-intensity warfarin after a thromboembolic event, some studies indicate that this degree of anticoagulation is not needed. There is an urgent need of clinical trials to address management of thrombosis in antiphospholipid syndrome.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0889-857X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
633-42, viii
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:11534265-Anticoagulants,
pubmed-meshheading:11534265-Antiphospholipid Syndrome,
pubmed-meshheading:11534265-Aspirin,
pubmed-meshheading:11534265-Hemorrhage,
pubmed-meshheading:11534265-Heparin,
pubmed-meshheading:11534265-Humans,
pubmed-meshheading:11534265-Lupus Erythematosus, Systemic,
pubmed-meshheading:11534265-Risk Factors,
pubmed-meshheading:11534265-Thrombosis,
pubmed-meshheading:11534265-Warfarin
|
pubmed:year |
2001
|
pubmed:articleTitle |
Management of thrombosis in antiphospholipid antibody syndrome.
|
pubmed:affiliation |
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. mpetri@welch.jhu.edu
|
pubmed:publicationType |
Journal Article,
Review
|